Consolidated Entities and Acquisitions - Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Aug. 22, 2022	Feb. 17, 2022	Dec. 31, 2021
Business Acquisition [Line Items]
Goodwill	$ 15,995			$ 0
La Jolla Pharmaceutical Company
Business Acquisition [Line Items]
Cash and cash equivalents		$ 47,415
Short-term marketable securities		471
Accounts receivable		5,876
Inventory		73,900
Prepaid expenses		1,261
Other current assets		907
Property and equipment, net		13
Right of use assets		226
Goodwill		12,711
Intangible assets pertain to product rights and developed technologies	152,500	152,500
Other assets		710
Total assets acquired		295,990
Accounts payable		1,237
Deferred revenue, current		2,849
Other accrued liabilities		11,062
Other long-term liabilities		74,283
Total liabilities assumed		89,431
Total assets acquired, net		$ 206,559
Entasis Therapeutics Holdings Inc
Business Acquisition [Line Items]
Cash and cash equivalents			$ 23,070
Prepaid expenses			5,554
Other current assets			1,959
Property and equipment, net			185
Right of use assets			959
Goodwill			3,284
Intangible assets pertain to product rights and developed technologies	$ 107,500		107,500
Other assets			302
Total assets acquired			142,813
Accounts payable			1,583
Accrued personnel-related expenses			1,057
Other current liabilities			5,097
Deferred tax liabilities			360
Total liabilities assumed			8,097
Total assets acquired, net			$ 134,716